BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(10): 2542-2554 [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang J, Yan Z, Feng Q, Yu L, Wang H. The Roles of Neutrophils in the Pathogenesis of Liver Diseases. Front Immunol 2021;12:625472. [PMID: 33763069 DOI: 10.3389/fimmu.2021.625472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Adenote A, Dumic I, Madrid C, Barusya C, Nordstrom CW, Rueda Prada L. NAFLD and Infection, a Nuanced Relationship. Can J Gastroenterol Hepatol 2021;2021:5556354. [PMID: 33977096 DOI: 10.1155/2021/5556354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
4 Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55-66. [PMID: 27924081 DOI: 10.1038/nrgastro.2016.168] [Cited by in Crossref: 168] [Cited by in F6Publishing: 155] [Article Influence: 28.0] [Reference Citation Analysis]
5 Tsiaoussis GI, Assimakopoulos SF, Tsamandas AC, Triantos CK, Thomopoulos KC. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications. World J Hepatol 2015; 7(17): 2058-2068 [PMID: 26301048 DOI: 10.4254/wjh.v7.i17.2058] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
6 Asrani SK, Kamath PS. Editorial: neutrophil dysfunction in patients with cirrhosis. Aliment Pharmacol Ther 2014;40:986. [PMID: 25229815 DOI: 10.1111/apt.12915] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Shi X, DeLucia AL, Bao J, Zhang P. Alcohol abuse and disorder of granulopoiesis. Pharmacol Ther 2019;198:206-19. [PMID: 30831129 DOI: 10.1016/j.pharmthera.2019.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Villarreal E, Vacacela K, Gordon M, Calabuig C, Alonso R, Ruiz J, Kot P, Babiloni D, Ramírez P. Usefulness of procalcitonin for diagnosing infection in critically ill patients with liver cirrhosis. Medicina Intensiva (English Edition) 2016;40:84-9. [DOI: 10.1016/j.medine.2015.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Singh H, Pai CG. Defining acute-on-chronic liver failure: East, West or Middle ground? World J Hepatol 2015; 7(25): 2571-2577 [PMID: 26557949 DOI: 10.4254/wjh.v7.i25.2571] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Liang J, Liu L, Cao Y, Zhang Q, Liu F, Chen Y, Liu H, Duan Z, Xu M, Xin S, You S, Song F, Li J, Han T. Hepatitis B-related acute-on-chronic liver failure induced by hepatotropic viral insult is associated with worse prognosis than that induced by non-virus insult. BMC Infect Dis 2021;21:1273. [PMID: 34930163 DOI: 10.1186/s12879-021-06974-z] [Reference Citation Analysis]
11 Yang D, Xie Y, Pan H, Huang Y, Dai Y, Tong Y, Chen M. Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome. Hepatol Res. 2017;47:1174-1185. [PMID: 28249358 DOI: 10.1111/hepr.12886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bruns T, Reuken PA, Stengel S, Gerber L, Appenrodt B, Schade JH, Lammert F, Zeuzem S, Stallmach A. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection. Liver Int 2016;36:1133-42. [PMID: 26901072 DOI: 10.1111/liv.13095] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
13 Shinohara T, Okamoto K, Koyano S, Otani A, Yamashita M, Wakimoto Y, Jubishi D, Hashimoto H, Ikeda M, Harada S, Okugawa S, Moriya K. Plesiomonas shigelloides Septic Shock Following Ingestion of Dojo Nabe (Loach Hotpot). Open Forum Infect Dis 2021;8:ofab401. [PMID: 34409126 DOI: 10.1093/ofid/ofab401] [Reference Citation Analysis]
14 Reuken PA, Kussmann A, Kiehntopf M, Budde U, Stallmach A, Claus RA, Bruns T. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis. Liver Int 2015;35:37-45. [PMID: 25113276 DOI: 10.1111/liv.12657] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
15 Villarreal E, Vacacela K, Gordon M, Calabuig C, Alonso R, Ruiz J, Kot P, Babiloni D, Ramírez P. Usefulness of procalcitonin for diagnosing infection in critically ill patients with liver cirrhosis. Med Intensiva. 2015;Epub ahead of print. [PMID: 25843699 DOI: 10.1016/j.medin.2015.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Chen YX, Lai LN, Zhang HY, Bi YH, Meng L, Li XJ, Tian XX, Wang LM, Fan YM, Zhao ZF, Han DW, Ji C. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis. World J Gastroenterol 2016; 22(10): 2949-2959 [PMID: 26973391 DOI: 10.3748/wjg.v22.i10.2949] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
17 Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, Castelli F, Bassetti M, Barbaro F, Grossi P, Barzaghi N, Rizzi M, Minoli L. Infective endocarditis in patients with hepatic diseases. Eur J Clin Microbiol Infect Dis 2016;35:279-84. [PMID: 26690071 DOI: 10.1007/s10096-015-2541-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Chen J, Huang ZB, Li H, Zheng X, Chen JJ, Wang XB, Qian ZP, Liu XX, Fan XG, Hu XW, Liao CJ, Long LY, Huang Y. Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study. Infect Dis Ther 2021;10:281-90. [PMID: 33146854 DOI: 10.1007/s40121-020-00362-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kedarisetty CK, Kumar A, Sarin SK. Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis. Semin Liver Dis 2021;41:67-78. [PMID: 33764486 DOI: 10.1055/s-0040-1719177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wang C, Ma D, Luo S, Wang C, Ding D, Tian Y, Ao K, Zhang Y, Chen Y, Meng Z. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. WJCC 2019;7:2204-16. [DOI: 10.12998/wjge.v7.i16.2204] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
21 Verna EC, Pereira MR. Transplanting patients with active bacterial infection. Clin Liver Dis (Hoboken) 2017;9:81-5. [PMID: 30992965 DOI: 10.1002/cld.624] [Reference Citation Analysis]
22 Bruns T, Nuraldeen R, Mai M, Stengel S, Zimmermann HW, Yagmur E, Trautwein C, Stallmach A, Strnad P. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis. Liver Int. 2017;37:232-241. [PMID: 27473364 DOI: 10.1111/liv.13211] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
23 Kedarisetty CK, Anand L, Bhardwaj A, Bhadoria AS, Kumar G, Vyas AK, David P, Trehanpati N, Rastogi A, Bihari C, Maiwall R, Garg HK, Vashishtha C, Kumar M, Bhatia V, Sarin SK. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology 2015;148:1362-70.e7. [PMID: 25749502 DOI: 10.1053/j.gastro.2015.02.054] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 9.7] [Reference Citation Analysis]
24 Liu QC, Liu LL, Ren Y, Lin SD. Neutrophil dysfunction in patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2015; 23(30): 4838-4843 [DOI: 10.11569/wcjd.v23.i30.4838] [Reference Citation Analysis]
25 Béjar-serrano S, del Pozo P, Fernández-de la Varga M, Benlloch S. Infecciones por bacterias multirresistentes en pacientes cirróticos en un hospital terciario. Gastroenterología y Hepatología 2019;42:228-38. [DOI: 10.1016/j.gastrohep.2018.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, Chawla YK, Dokmeci AK, Garg H, Ghazinyan H, Hamid S, Kim DJ, Komolmit P, Lata S, Lee GH, Lesmana LA, Mahtab M, Maiwall R, Moreau R, Ning Q, Pamecha V, Payawal DA, Rastogi A, Rahman S, Rela M, Saraya A, Samuel D, Saraswat V, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Butt AS, Tan SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O;  APASL ACLF Working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8:453-471. [PMID: 26202751 DOI: 10.1007/s12072-014-9580-2] [Cited by in Crossref: 354] [Cited by in F6Publishing: 306] [Article Influence: 44.3] [Reference Citation Analysis]
27 Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, Fung CP, Hsu HC, Hou MC, Lin HC. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients. J Microbiol Immunol Infect 2017;50:905-14. [PMID: 26872435 DOI: 10.1016/j.jmii.2015.12.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Del Bono V, Giacobbe DR. Bloodstream infections in internal medicine. Virulence 2016;7:353-65. [PMID: 26760780 DOI: 10.1080/21505594.2016.1140296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
29 Habib S, Yarlagadda S, Carreon TA, Schader LM, Hsu CH. Fungal Infection in Acutely Decompensated Cirrhosis Patients: Value of Model for End-Stage Liver Disease Score. Gastroenterology Res 2020;13:199-207. [PMID: 33224366 DOI: 10.14740/gr1255] [Reference Citation Analysis]
30 Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Song DS, Yang JM, Yoon EL;  APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353-390. [PMID: 31172417 DOI: 10.1007/s12072-019-09946-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 44.7] [Reference Citation Analysis]
31 Dong V, Karvellas CJ. Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit. JHEP Rep 2019;1:44-52. [PMID: 32039351 DOI: 10.1016/j.jhepr.2019.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
32 Raasch M, Fritsche E, Kurtz A, Bauer M, Mosig AS. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development. Adv Drug Deliv Rev 2019;140:51-67. [PMID: 29908880 DOI: 10.1016/j.addr.2018.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
33 Son J, Choi S, Huh JW, Lim CM, Koh Y, Kim KM, Shim JH, Lim YS, Hong SB. The quick sepsis-related organ failure score has limited value for predicting adverse outcomes in sepsis patients with liver cirrhosis. Korean J Intern Med. 2019;. [PMID: 31645093 DOI: 10.3904/kjim.2018.229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Wang C, Ma DQ, Luo S, Wang CM, Ding DP, Tian YY, Ao KJ, Zhang YH, Chen Y, Meng ZJ. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2019; 7(16): 2204-2216 [PMID: 31531315 DOI: 10.12998/wjcc.v7.i16.2204] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
35 Yarbakht M, Pradhan P, Köse-vogel N, Bae H, Stengel S, Meyer T, Schmitt M, Stallmach A, Popp J, Bocklitz TW, Bruns T. Nonlinear Multimodal Imaging Characteristics of Early Septic Liver Injury in a Mouse Model of Peritonitis. Anal Chem 2019;91:11116-21. [DOI: 10.1021/acs.analchem.9b01746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
36 Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, Alonso-López S, Fernández-Rodríguez CM. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2015; 21(42): 12125-12140 [PMID: 26576097 DOI: 10.3748/wjg.v21.i42.12125] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
37 Yang YY, Hsu YC. Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock. BMC Infect Dis 2021;21:483. [PMID: 34039297 DOI: 10.1186/s12879-021-06194-5] [Reference Citation Analysis]
38 Ekpanyapong S, Reddy KR. Infections in Cirrhosis. Curr Treat Options Gastroenterol. 2019;17:254-270. [PMID: 30980335 DOI: 10.1007/s11938-019-00229-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
39 Mai M, Stengel S, Al-Herwi E, Peter J, Schmidt C, Rubio I, Stallmach A, Bruns T. Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: A combined prospective-retrospective study. Sci Rep 2017;7:4914. [PMID: 28687809 DOI: 10.1038/s41598-017-04895-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
40 Borgonovo A, Baldin C, Maggi DC, Victor L, Bansho ETO, Piedade J, Wildner LM, Guimarães L, Bazzo ML, Rocha T, Dantas-Corrêa EB, Alcântara C, Fernandes F, Narciso-Schiavon JL, Pereira GHS, Schiavon LL. Systemic Inflammatory Response Syndrome in Patients Hospitalized for Acute Decompensation of Cirrhosis. Can J Gastroenterol Hepatol 2021;2021:5581587. [PMID: 33987144 DOI: 10.1155/2021/5581587] [Reference Citation Analysis]
41 Vogt A, Reuken PA, Stengel S, Stallmach A, Bruns T. Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study. World J Gastroenterol 2016; 22(11): 3275-3284 [PMID: 27004006 DOI: 10.3748/wjg.v22.i11.3275] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
42 Bauer M, Coldewey SM, Leitner M, Löffler B, Weis S, Wetzker R. Deterioration of Organ Function As a Hallmark in Sepsis: The Cellular Perspective. Front Immunol 2018;9:1460. [PMID: 29997622 DOI: 10.3389/fimmu.2018.01460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
43 Wong F, O'Leary JG, Reddy KR, Garcia-Tsao G, Fallon MB, Biggins SW, Subramanian RM, Thuluvath PJ, Kamath PS, Patton H, Maliakkal B, Tandon P, Vargas H, Thacker L, Bajaj JS. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes. Am J Gastroenterol 2017;112:1103-10. [PMID: 28440305 DOI: 10.1038/ajg.2017.122] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
44 Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol 2015; 7(16): 1974-1981 [PMID: 26261687 DOI: 10.4254/wjh.v7.i16.1974] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
45 Ferrarese A, Zanetto A, Becchetti C, Sciarrone SS, Shalaby S, Germani G, Gambato M, Russo FP, Burra P, Senzolo M. Management of bacterial infection in the liver transplant candidate. World J Hepatol 2018; 10(2): 222-230 [PMID: 29527258 DOI: 10.4254/wjh.v10.i2.222] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
46 Heung M, Koyner JL. Entanglement of Sepsis, Chronic Kidney Disease, and Other Comorbidities in Patients Who Develop Acute Kidney Injury. Seminars in Nephrology 2015;35:23-37. [DOI: 10.1016/j.semnephrol.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ibidapo-Obe O, Stengel S, Köse-Vogel N, Quickert S, Reuken PA, Busch M, Bauer M, Stallmach A, Bruns T. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation. Cell Mol Gastroenterol Hepatol 2020;9:661-77. [PMID: 31954178 DOI: 10.1016/j.jcmgh.2020.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
48 Jain M, Varghese J, Michael T, Kedarishetty CK, G B, Swaminathan S, Venkataraman J. An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver Disease. J Clin Exp Hepatol 2017;7:305-9. [PMID: 29234194 DOI: 10.1016/j.jceh.2017.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
49 Tan YY, Montagnese S, Mani AR. Organ System Network Disruption Is Associated With Poor Prognosis in Patients With Chronic Liver Failure. Front Physiol 2020;11:983. [PMID: 32848892 DOI: 10.3389/fphys.2020.00983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Mu X, Tong J, Xu X, Chen J, Su H, Liu X, Pang F, Zhai X, Wang L, Wang Y, Guan C, Wang F, Hu J. World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol 2021;45:101548. [PMID: 33554865 DOI: 10.1016/j.clinre.2020.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
51 Álvaro-Meca A, Jiménez-Sousa MA, Boyer A, Medrano J, Reulen H, Kneib T, Resino S. Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit. BMC Infect Dis 2016;16:122. [PMID: 26979964 DOI: 10.1186/s12879-016-1448-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13:131-149. [PMID: 26837712 DOI: 10.1038/nrgastro.2015.219] [Cited by in Crossref: 141] [Cited by in F6Publishing: 132] [Article Influence: 23.5] [Reference Citation Analysis]
53 Christina YI, Diana MR, Fuzianingsih EN, Nurhayati, Ridwan FN, Widodo, Rifa'i M, Djati MS. Hormone-balancing and protective effect of combined extract of Sauropus androgynus and Elephantopus scaber against Escherichia coli-induced renal and hepatic necrosis in pregnant mice. J Ayurveda Integr Med 2021;12:245-53. [PMID: 32958334 DOI: 10.1016/j.jaim.2020.09.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Bajaj JS. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther. 2016;43 Suppl 1:11-26. [PMID: 26618922 DOI: 10.1111/apt.13435] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
55 Bossen L, Dam GA, Vilstrup H, Watson H, Jepsen P. Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites. JHEP Rep 2019;1:265-9. [PMID: 32039377 DOI: 10.1016/j.jhepr.2019.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Wang JZ, Zhang Y, Guo Q. Thoughts on factors related to colonoscopy quality. Shijie Huaren Xiaohua Zazhi 2021; 29(17): 977-983 [DOI: 10.11569/wcjd.v29.i17.977] [Reference Citation Analysis]
57 Wang X, Sarin SK, Ning Q. Definition of ACLF and inclusion criteria for extra-hepatic organ failure. Hepatol Int 2015;9:360-5. [PMID: 26016465 DOI: 10.1007/s12072-015-9637-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
58 Sarin SK, Choudhury A. Acute-on-chronic Liver Failure. Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0535-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
59 Acevedo J. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies. World J Hepatol 2015; 7(7): 916-921 [PMID: 25954474 DOI: 10.4254/wjh.v7.i7.916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
60 Kirplani PD, Qadar LT, Ochani RK, Memon ZA, Tahir SA, Imran K, Kumar Seetlani N, Abbasi A, Kumar M, Ali P. Recognition of Antibiotic Resistance in Spontaneous Bacterial Peritonitis Caused by Escherichia coli in Liver Cirrhotic Patients in Civil Hospital Karachi. Cureus 2019;11:e5284. [PMID: 31576274 DOI: 10.7759/cureus.5284] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: Global trends and future challenges. World J Gastroenterol 2019; 25(2): 190-204 [PMID: 30670909 DOI: 10.3748/wjg.v25.i2.190] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 24] [Article Influence: 11.3] [Reference Citation Analysis]
62 Stengel S, Quickert S, Lutz P, Ibidapo-Obe O, Steube A, Köse-Vogel N, Yarbakht M, Reuken PA, Busch M, Brandt A, Bergheim I, Deshmukh SD, Stallmach A, Bruns T. Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis. Gastroenterology 2020;158:1745-61. [PMID: 31982413 DOI: 10.1053/j.gastro.2020.01.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
63 Peng AP, Zhu X. Updates on pathogenesis, diagnosis and treatment of hepatorenal syndrome. Shijie Huaren Xiaohua Zazhi 2015; 23(9): 1440-1446 [DOI: 10.11569/wcjd.v23.i9.1440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Milovanovic T, Dumic I, Veličkovic J, Lalosevic MS, Nikolic V, Palibrk I. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia. BMC Infect Dis 2019;19:141. [PMID: 30755176 DOI: 10.1186/s12879-019-3761-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
65 Calik Basaran N, Ascioglu S. Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature. Ther Adv Infect Dis 2017;4:171-91. [PMID: 29662673 DOI: 10.1177/2049936117733394] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Khamri W, Gudd C, Liu T, Nathwani R, Krasniqi M, Azam S, Barbera T, Trovato FM, Possamai L, Triantafyllou E, Seoane RC, Lebosse F, Singanayagam A, Kumar N, Bernsmeier C, Mukherjee S, McPhail M, Weston CJ, Antoniades CG, Thursz MR. Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis. Gut 2021:gutjnl-2021-324071. [PMID: 34344786 DOI: 10.1136/gutjnl-2021-324071] [Reference Citation Analysis]
67 Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG. Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World J Hepatol 2016; 8(35): 1569-1575 [PMID: 28050238 DOI: 10.4254/wjh.v8.i35.1569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]